BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 29, 2013
View Archived Issues
Alnylam Pharmaceuticals divulges new siRNAs for bleeding disorders
Read More
Sepsis and aging studied in Drosophila model
Read More
Interim data presented for FG-3019 in patients with PDAC
Read More
KLF6 gene variant is strongly associated with breast cancer metastasis
Read More
Interim data from phase I RRx-001 study available
Read More
Preliminary phase I results presented for golvatinib plus sorafenib in HCC
Read More
Merck KGaA designs novel FSH receptor agonists
Read More
Chinese researchers disclose new SGLT2 inhibitors
Read More
Abbott presents new PDE10A inhibitors
Read More
Shanghai Institute of Materia Medica synthesizes new PLA2 inhibitors
Read More
Newron Pharmaceuticals patents new sodium and/or calcium channel blockers
Read More
Ipca Laboratories prepares new platelet adhesion inhibitors
Read More
First patient treated in GCS-100 phase I/II trial
Read More
Zerenex meets primary and secondary endpoints in phase III trial
Read More
Hanmi Pharmaceutical finds partner to market esomeprazole strontium
Read More
EC approves BindRen for hyperphosphatemia
Read More
Companies collaborate on combination studies of simeprevir, TMC-647055 and IDX-719
Read More
SP-333 advances into phase Ib study
Read More
Chugai seeks Japanese approval of trastuzumab emtansine
Read More
Charleston Laboratories begins phase III trial of CL-108
Read More
Dipraglurant shows promise in rodent model of dystonia
Read More
Protein S100-A10 has prognostic significance in pancreatic cancer
Read More
Grants supports The Scripps Research Institute's research on ASK-1
Read More
Phase III program of latanoprostene bunod begins
Read More
Delay to topline results from first pivotal study of Androxal
Read More
ReNeuron advances PISCES study of ReN-001 stem cell therapy for stroke
Read More
MolecularMD obtains license to LKB1 use in NSCLC
Read More